These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 1679298)

  • 1. Conjunctival impression cytology in patients with glaucoma using long-term topical medication.
    Brandt JD; Wittpenn JR; Katz LJ; Steinmann WN; Spaeth GL
    Am J Ophthalmol; 1991 Sep; 112(3):297-301. PubMed ID: 1679298
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adverse effects of topical antiglaucomatous medications on the conjunctiva and the lachrymal (Brit. Engl) response.
    Nuzzi R; Finazzo C; Cerruti A
    Int Ophthalmol; 1998; 22(1):31-5. PubMed ID: 10090446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of long-term topical glaucoma medication on conjunctival impression cytology.
    Turaçli E; Budak K; Kaur A; Mizrak B; Ekinci C
    Int Ophthalmol; 1997; 21(1):27-33. PubMed ID: 9298420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of topical antiglaucoma application on conjunctival impression cytology specimens.
    Hong S; Lee CS; Seo KY; Seong GJ; Hong YJ
    Am J Ophthalmol; 2006 Jul; 142(1):185-6. PubMed ID: 16815281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effects of topical antiglaucoma drugs on the ocular surface.
    Arici MK; Arici DS; Topalkara A; Güler C
    Clin Exp Ophthalmol; 2000 Apr; 28(2):113-7. PubMed ID: 10933774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Structural and immunohistochemical changes of conjunctiva induced by topical glaucoma medication].
    Nenciu A; Stefan C; Ardelean C
    Oftalmologia; 2004; 48(1):35-42. PubMed ID: 15279417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morphology of conjunctiva after long-term topical anti-glaucoma treatment. A quantitative analysis.
    Baun O; Heegaard S; Kessing SV; Prause JU
    Acta Ophthalmol Scand; 1995 Jun; 73(3):242-5. PubMed ID: 7493236
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [1991 new developments regarding the conjunctiva].
    Kneer I; Höh H; Ruprecht KW
    Klin Monbl Augenheilkd; 1993 Dec; 203(6):380-3. PubMed ID: 7908349
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiglaucoma drugs on ocular surface.
    Yalvaç IS; Gedikoğlu G; Karagöz Y; Akgün U; Nurözler A; Koç F; Kasim R; Duman S
    Acta Ophthalmol Scand; 1995 Jun; 73(3):246-8. PubMed ID: 7493237
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Conjunctival changes related to topical treatment and effectiveness of surgery in glaucoma].
    Stefan C; Nenciu A; Balas M; Neacşu A; Dachin L; Ardelean C
    Oftalmologia; 2003; 59(4):19-23. PubMed ID: 15083680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ocular surface inflammatory changes induced by topical antiglaucoma drugs: human and animal studies.
    Baudouin C; Pisella PJ; Fillacier K; Goldschild M; Becquet F; De Saint Jean M; Béchetoille A
    Ophthalmology; 1999 Mar; 106(3):556-63. PubMed ID: 10080214
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An in vivo confocal microscopy and impression cytology analysis of preserved and unpreserved levobunolol-induced conjunctival changes.
    Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Lanzini M; Calienno R; Mastropasqua L
    Eur J Ophthalmol; 2008; 18(3):400-7. PubMed ID: 18465723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Goblet cells density of bulbar conjunctiva after long-term topical antiglaucoma agents].
    Wróblewska E
    Klin Oczna; 1999; 101(1):45-7. PubMed ID: 10401215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Squamous metaplasia of bulbar conjunctiva in the course of long-term topical antiglaucoma therapy].
    Wróblewska E
    Klin Oczna; 1999; 101(1):41-3. PubMed ID: 10401214
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early conjunctival changes following treatment with metipranolol and preservatives are not reversible with dexamethasone.
    Mietz H; Schlötzer-Schrehardt U; Lemke JH; Krieglstein GK
    Graefes Arch Clin Exp Ophthalmol; 1997 Jul; 235(7):452-9. PubMed ID: 9248843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of inflammatory membrane markers by conjunctival cells in chronically treated patients with glaucoma.
    Baudouin C; Garcher C; Haouat N; Bron A; Gastaud P
    Ophthalmology; 1994 Mar; 101(3):454-60. PubMed ID: 7907416
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of topical antiglaucoma medication. I. The conjunctival cell profile.
    Broadway DC; Grierson I; O'Brien C; Hitchings RA
    Arch Ophthalmol; 1994 Nov; 112(11):1437-45. PubMed ID: 7980133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo confocal microscopy of conjunctiva in preservative-free timolol 0.1% gel formulation therapy for glaucoma.
    Frezzotti P; Fogagnolo P; Haka G; Motolese I; Iester M; Bagaglia SA; Mittica P; Menicacci C; Rossetti L; Motolese E
    Acta Ophthalmol; 2014 Mar; 92(2):e133-40. PubMed ID: 24020826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of topical antiglaucoma medication effects on the conjunctiva.
    Broadway DC; Grierson I; Stürmer J; Hitchings RA
    Arch Ophthalmol; 1996 Mar; 114(3):262-7. PubMed ID: 8600884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Conjunctival modifications in ocular hypertension and primary open angle glaucoma: an in vivo confocal microscopy study.
    Ciancaglini M; Carpineto P; Agnifili L; Nubile M; Fasanella V; Mastropasqua L
    Invest Ophthalmol Vis Sci; 2008 Jul; 49(7):3042-8. PubMed ID: 18316705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.